ReviewThe journal of spinal cord medicine2022

A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury.

Celine Lakra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.